SBI Life Insurance Co (NSE:SBILIFE) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


NSE:SBILIFE SBI Life Insurance Co Ltd NSE:SBILIFE
81 GF Score
Price ₹1,790.90
GF Value ₹2,002.97
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is SBI Life Insurance Co Research & Development?

SBI Life Insurance Co NSE:SBILIFE +1.43% 81 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:SBILIFE with a GF Score™ of 81/100 and a GF Value™ of ₹2,002.97 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. SBI Life Insurance Co's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

SBI Life Insurance Co  (NSE:SBILIFE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SBI Life Insurance Co Research & Development Related Terms

SBI Life Insurance Co Research & Development Historical Data

* Premium members only.

The historical data trend for SBI Life Insurance Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SBI Life Insurance Co Research & Development Chart

SBI Life Insurance Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SBI Life Insurance Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SBILIFE
81GF Score
SBI Life Insurance Co Ltd NSE:SBILIFE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SBI Life Insurance Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
SBI Life Insurance Co (NSE:SBILIFE) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on SBI Life Insurance Co and its competitors.
Is SBI Life Insurance Co's Research & Development too high?
SBI Life Insurance Co's current Research & Development is ₹0 Mil. Overall, SBI Life Insurance Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SBI Life Insurance Co's Research & Development compare to AFL and MET?
SBI Life Insurance Co's Research & Development of ₹0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on SBI Life Insurance Co and its competitors. SBI Life Insurance Co's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SBI Life Insurance Co stock overvalued right now?
Based on GuruFocus' analysis, SBI Life Insurance Co (NSE:SBILIFE) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,002.97, compared to a current price of ₹1,790.90 — trading 10.6% below its estimated fair value. The current Research & Development is ₹0 Mil. SBI Life Insurance Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For SBI Life Insurance Co (NSE:SBILIFE), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SBI Life Insurance Co (NSE:SBILIFE) Overvalued in 2026?

Based on GuruFocus' analysis, SBI Life Insurance Co stock appears to be undervalued. The current stock price of ₹1,790.90 is trading 10.6% below its estimated GF Value™ of ₹2,002.97. GuruFocus considers SBI Life Insurance Co to be Modestly Undervalued.

Key valuation signals for NSE:SBILIFE:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹2,002.97 vs. price of ₹1,790.90 (10.6% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the NSE:SBILIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SBI Life Insurance Co Business Description

Other Exchanges 540719:India
Address M. V. Road and Western Express Highway Junction, Natraj, Andheri East, Mumbai, MH, IND, 400069
SBI Life Insurance Co Ltd is a life insurance company in India. The company offers insurance products for individuals and groups, including Poorna Suraksha, Sampoorn Cancer Suraksha, eShield, CapAssure Gold, and others. The company has many products catering to various customer needs in the life, health, pension, and micro-insurance segments. The company operates through the following segments: Participating, Non-Participating, and Linked. The company derives the majority of its revenue from the Non-Participating segment, which includes endowment products, a variable insurance plan, an immediate annuity product, group protection products, and others.
81GF Score

Get the complete analysis for NSE:SBILIFE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,790.90
Price
₹2,002.97
GF Value